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Assembling cell-free, cascading multi-enzyme enzyme reactions into artificial metabolic networks for the 
conversion of low value renewable feedstocks into high value products represents a fourth wave of biocatalysis 
for renewable green chemistry and synthetic biology applications [1].  However, major limitations to both 
applications include the cost of producing multiple purified enzymes and of providing a continuous supply of 
diffusible cofactors or cosubstrates [2].  We have applied synthetic biology principles to produce fusion proteins 
between synthetic enzymes and their cofactor-recycling partner enzymes, with concomitant in situ recycling of a 
modified tethered cofactor, with an added conjugation protein element to allow immobilization of the 
nanomachines to a surface.   This has enabled the construction of nanomachine flow reactors which can be 
combined in an interchangeable, “plug-and-play” manner to construct complex synthetic networks or 
Nanofactories.   Synthesis of the anti-diabetic drug, D-fagomine, reductive amination to produce various chiral or 
conjugated amines (Fig. 1) and deracemization of alcohols have been used to exemplify the principles, and we 
have demonstrated tethered cofactor recycling of ATP, NAD(H)+ and NADP(H)+, as well as ligand-directed 
immobilization of a variety of enzymes to illustrate the use of these nanomachine biocatalysts as tools for the de 
novo construction of in vitro metabolic networks for synthetic biology.  Our research is currently exploring the 
use of frugal innovation principles to integrate key capabilities in reactor design with on-line analytics for real-
time reaction monitoring, and, subsequently, dynamic control over the platform’s fluidics via feedback loops. We 
aim to demonstrate the utility of such systems for cell-free metabolic engineering to enable fine chemical 
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Figure 1 – Nanomachines: engineered 
enzymes that retain and regenerate their 
cofactors enable cell-free metabolic 
engineering. 
 
